Author:
Publisher:
ISBN:
Category :
Languages : en
Pages :
Book Description
Lt. Col. Carl E. Welchner. June 9 (legislative Day, May 13), 1954. -- Ordered to be Printed
Author:
Publisher:
ISBN:
Category :
Languages : en
Pages :
Book Description
Publisher:
ISBN:
Category :
Languages : en
Pages :
Book Description
Report
Author: United States. Congress Senate
Publisher:
ISBN:
Category : United States
Languages : en
Pages : 2700
Book Description
Publisher:
ISBN:
Category : United States
Languages : en
Pages : 2700
Book Description
Congressional Record
Author: United States. Congress
Publisher:
ISBN:
Category : Law
Languages : en
Pages : 1210
Book Description
Publisher:
ISBN:
Category : Law
Languages : en
Pages : 1210
Book Description
Preclinical Development Handbook
Author: Shayne Cox Gad
Publisher: John Wiley & Sons
ISBN: 0470249021
Category : Medical
Languages : en
Pages : 1352
Book Description
A clear, straightforward resource to guide you through preclinical drug development Following this book's step-by-step guidance, you can successfully initiate and complete critical phases of preclinical drug development. The book serves as a basic, comprehensive reference to prioritizing and optimizing leads, dose formulation, ADME, pharmacokinetics, modeling, and regulations. This authoritative, easy-to-use resource covers all the issues that need to be considered and provides detailed instructions for current methods and techniques. Each chapter is written by one or more leading experts in the field. These authors, representing the many disciplines involved in preclinical toxicology screening and testing, give you the tools needed to apply an effective multidisciplinary approach. The editor has carefully reviewed all the chapters to ensure that each one is thorough, accurate, and clear. Among the key topics covered are: * Modeling and informatics in drug design * Bioanalytical chemistry * Absorption of drugs after oral administration * Transporter interactions in the ADME pathway of drugs * Metabolism kinetics * Mechanisms and consequences of drug-drug interactions Each chapter offers a full exploration of problems that may be encountered and their solutions. The authors also set forth the limitations of various methods and techniques used in determining the safety and efficacy of a drug during the preclinical stage. This publication should be readily accessible to all pharmaceutical scientists involved in preclinical testing, enabling them to perform and document preclinical safety tests to meet all FDA requirements before clinical trials may begin.
Publisher: John Wiley & Sons
ISBN: 0470249021
Category : Medical
Languages : en
Pages : 1352
Book Description
A clear, straightforward resource to guide you through preclinical drug development Following this book's step-by-step guidance, you can successfully initiate and complete critical phases of preclinical drug development. The book serves as a basic, comprehensive reference to prioritizing and optimizing leads, dose formulation, ADME, pharmacokinetics, modeling, and regulations. This authoritative, easy-to-use resource covers all the issues that need to be considered and provides detailed instructions for current methods and techniques. Each chapter is written by one or more leading experts in the field. These authors, representing the many disciplines involved in preclinical toxicology screening and testing, give you the tools needed to apply an effective multidisciplinary approach. The editor has carefully reviewed all the chapters to ensure that each one is thorough, accurate, and clear. Among the key topics covered are: * Modeling and informatics in drug design * Bioanalytical chemistry * Absorption of drugs after oral administration * Transporter interactions in the ADME pathway of drugs * Metabolism kinetics * Mechanisms and consequences of drug-drug interactions Each chapter offers a full exploration of problems that may be encountered and their solutions. The authors also set forth the limitations of various methods and techniques used in determining the safety and efficacy of a drug during the preclinical stage. This publication should be readily accessible to all pharmaceutical scientists involved in preclinical testing, enabling them to perform and document preclinical safety tests to meet all FDA requirements before clinical trials may begin.
Karl L. Von Schleider. June 9 (legislative Day, May 13), 1954. -- Ordered to be Printed
Author:
Publisher:
ISBN:
Category :
Languages : en
Pages :
Book Description
Publisher:
ISBN:
Category :
Languages : en
Pages :
Book Description
Willard Chester Cauley. June 9 (legislative Day, May 13), 1954. -- Ordered to be Printed
Author:
Publisher:
ISBN:
Category :
Languages : en
Pages :
Book Description
Publisher:
ISBN:
Category :
Languages : en
Pages :
Book Description
The Federal Bureau of Investigation
Author: Max Lowenthal
Publisher:
ISBN:
Category : Internal security
Languages : en
Pages : 584
Book Description
Publisher:
ISBN:
Category : Internal security
Languages : en
Pages : 584
Book Description
Richard A. Kurth. June 9 (legislative Day, May 13), 1954. -- Ordered to be Printed
Author:
Publisher:
ISBN:
Category :
Languages : en
Pages :
Book Description
Publisher:
ISBN:
Category :
Languages : en
Pages :
Book Description
Huntington, McLaren & Co. June 9 (legislative Day, May 13), 1954. -- Ordered to be Printed
Author:
Publisher:
ISBN:
Category :
Languages : en
Pages :
Book Description
Publisher:
ISBN:
Category :
Languages : en
Pages :
Book Description
Carl A. Annis, Wayne C. Cranney, and Leslie O. Yarwood. June 9 (legislative Day, May 13), 1954. -- Ordered to be Printed
Author:
Publisher:
ISBN:
Category :
Languages : en
Pages :
Book Description
Publisher:
ISBN:
Category :
Languages : en
Pages :
Book Description